iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 2,795.00
+5.00 (0.18%)
Nov 2, 2026, 3:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 86.34 billion as of October 30, 2026. It is the 28,211th most valuable company in the world and the 1,351st biggest in South Korea. Its market cap has decreased by 17.74% in one year.
Market Cap
86.34B
Enterprise Value
47.92B
Revenue
5.74B
Global Rank
Country Rank
#1,351 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has decreased from 95.30B to 86.34B, a decrease of -9.40%. That is a compound annual growth rate of -0.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 86.34B | -15.96% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 170.37B |
| NeoImmuneTech | 155.82B |
| GC Cell | 151.77B |
| Anterogen.Co.,Ltd. | 133.68B |
| MedPacto | 104.54B |
| Genexine | 98.24B |
| Vaxcell-Bio Therapeutics | 86.63B |
| Amicogen | 64.54B |